Literature DB >> 12225325

Regulatory elements of hepatitis B virus transcription.

Naazneen Moolla1, Michael Kew, Patrick Arbuthnot.   

Abstract

The precise modulation of hepatitis B virus (HBV) gene expression is essential for replication of the virus. HBV sequences are transcribed under the control of the preC/pregenomic, S1, S2 and X promoters. With the exception of S1, all the HBV promoters lack the orthodox TATA box motifs required for the formation of the transcription initiation complex, and as such they represent a unique model of transcription initiation elements. The presence of two enhancer sequences and negative regulatory elements in the HBV genome further augments the controlled synthesis of HBV- RNA. All these transcription cis-elements are embedded within protein coding regions of the genome. This feature demonstrates the remarkable ability of the virus to maximize the function of its small genome. HBV transcription control elements also display a preference for liver-specific or liver-enriched trans-factors, which contributes to the liver tropism of the virus. This review outlines the major HBV transcription regulatory elements and highlights the reliance of accurate HBV gene modulation on the complex interplay between several trans-acting factors and their corresponding cis- motifs in the viral genome.

Entities:  

Mesh:

Year:  2002        PMID: 12225325     DOI: 10.1046/j.1365-2893.2002.00381.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  61 in total

Review 1.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

Review 2.  X region mutations of hepatitis B virus related to clinical severity.

Authors:  Hong Kim; Seoung-Ae Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

3.  Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle.

Authors:  Hironori Nishitsuji; Hiromi Yamamoto; Ritsuko Shiina; Keisuke Harada; Saneyuki Ujino; Kunitada Shimotohno
Journal:  J Vis Exp       Date:  2017-02-01       Impact factor: 1.355

4.  In vitro anti-hepatitis B virus effect of Hypericum perforatum L.

Authors:  Ran Pang; Junyan Tao; Shuling Zhang; Jiang Zhu; Xin Yue; Lei Zhao; Pian Ye; Ying Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

Review 5.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

6.  Mutations in Hepatitis-B X-Gene Region: Chronic Hepatitis-B versus Cirrhosis.

Authors:  Farzaneh Salarnia; Sima Besharat; Sare Zhand; Naeme Javid; Behnaz Khodabakhshi; Abdolvahab Moradi
Journal:  J Clin Diagn Res       Date:  2017-03-01

Review 7.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

8.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 9.  Core promoter: a critical region where the hepatitis B virus makes decisions.

Authors:  Jorge Quarleri
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Effects of two novel nucleoside analogues on different hepatitis B virus promoters.

Authors:  Xing-Xing He; Ju-Sheng Lin; Ying Chang; Ying-Hui Zhang; Yan Li; Xiao-Yan Wang; Dong Xu; Xiao-Ming Cheng
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.